This morphological and functional shift, suggestive of the acquisition of a more aggressive tumor cell phenotype, has been associated in our experimental model with changes in the expression level of classic EMT markers, such as loss of epithelial E-cadherin and upregulation of mesenchymal Vimentin. Here, CDH1 is linked to neoplasm.